Skip to main content
TipRanks
Go Ultimate75% OFF

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Stock Statistics & Valuation Metrics

61 Followers

Total Valuation

Fisher & Paykel Healthcare Corporation Limited has a market cap or net worth of $15.71B. The enterprise value is $21.78B.

Market Cap
$15.71B
Enterprise Value
$21.78B

Share Statistics

Fisher & Paykel Healthcare Corporation Limited has 588,265,440 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
588,265,440
Owned by Insiders
0.17%
Owned by Institutions
15.41%

Financial Efficiency

Fisher & Paykel Healthcare Corporation Limited’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 20.72%.

Return on Equity (ROE)
0.22
Return on Assets (ROA)
0.16
Return on Invested Capital (ROIC)
20.72%
Return on Capital Employed (ROCE)
0.28
Revenue Per Employee
316.25K
Profits Per Employee
63.35K
Employee Count
7,396
Asset Turnover
0.82
Inventory Turnover
2.56

Valuation Ratios

The current PE Ratio of Fisher & Paykel Healthcare Corporation Limited is 61.38. Fisher & Paykel Healthcare Corporation Limited’s PEG ratio is 1.72.

PE Ratio
61.38
PS Ratio
12.33
PB Ratio
13.62
Price to FCF
58.80
Price to Operating Cash Flow
43.45
PEG Ratio
1.72

Income Statement

In the last 12 months, Fisher & Paykel Healthcare Corporation Limited had revenue of 2.34B and earned 468.50M in profits. Earnings per share was 0.80.

Revenue
2.34B
Gross Profit
1.50B
Operating Income
667.00M
Pretax Income
631.50M
Net Income
468.50M
EBITDA
825.60M
Earnings Per Share (EPS)
0.80

Cash Flow

In the last 12 months, operating cash flow was 663.20M and capital expenditures -172.80M, giving a free cash flow of 490.40M billion.

Operating Cash Flow
663.20M
Free Cash Flow
490.40M
Free Cash Flow per Share
0.84

Dividends & Yields

Fisher & Paykel Healthcare Corporation Limited pays an annual dividend of $0.29, resulting in a dividend yield of 1.62%

Dividend Per Share
$0.29
Dividend Yield
1.62%
Payout Ratio
37.51%
Free Cash Flow Yield
1.72%
Earnings Yield
1.64%

Stock Price Statistics

Beta
0.34
52-Week Price Change
23.89%
50-Day Moving Average
26.34
200-Day Moving Average
23.57
Relative Strength Index (RSI)
47.86
Average Volume (3m)
2,454

Important Dates

Fisher & Paykel Healthcare Corporation Limited upcoming earnings date is Nov 25, 2026, After Close (Not Confirmed).

Last Earnings Date
May 25, 2026
Next Earnings Date
Nov 25, 2026
Ex-Dividend Date
Jun 23, 2026

Financial Position

Fisher & Paykel Healthcare Corporation Limited as a current ratio of 2.31, with Debt / Equity ratio of 6.91%

Current Ratio
2.31
Quick Ratio
1.66
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.38
Interest Coverage Ratio
64.76

Taxes

In the past 12 months, Fisher & Paykel Healthcare Corporation Limited has paid 163.00M in taxes.

Income Tax
163.00M
Effective Tax Rate
0.26

Enterprise Valuation

Fisher & Paykel Healthcare Corporation Limited EV to EBITDA ratio is 34.58, with an EV/FCF ratio of 57.58.

EV to Sales
12.07
EV to EBITDA
34.58
EV to Free Cash Flow
57.58
EV to Operating Cash Flow
42.58

Balance Sheet

Fisher & Paykel Healthcare Corporation Limited has $461.10M in cash and marketable securities with $146.10M in debt, giving a net cash position of $315.00M billion.

Cash & Marketable Securities
$461.10M
Total Debt
$146.10M
Net Cash
$315.00M
Net Cash Per Share
$0.54
Tangible Book Value Per Share
$3.48

Margins

Gross margin is 64.16%, with operating margin of 28.52%, and net profit margin of 20.03%.

Gross Margin
64.16%
Operating Margin
28.52%
Pretax Margin
27.00%
Net Profit Margin
20.03%
EBITDA Margin
34.92%
EBIT Margin
28.14%

Analyst Forecast

The average price target for Fisher & Paykel Healthcare Corporation Limited is $29.56, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$29.56
Price Target Upside
10.67% Upside
Analyst Consensus
Strong Buy
Analyst Count
8
Revenue Growth Forecast
14.41%
EPS Growth Forecast
22.98%